Background. Patients with active cancer are often on chronic anticoagu lation and frequently require interruption of this treatment for invasive procedures and/or chemotherapy. Few data are available on the impact of cancer on periprocedural thromboembolism (TE) and major bleeding.
Saccullo, G., Malato, A., Lo Coco, L., Mancuso, S., Abbadessa, V., Siragusa, S. (2012). CANCER AS A PREDICTOR FOR INCREASED PERIPROCEDURAL BLEEDING DURING SURGERY OR PLATELET-INDUCED CHEMOTHERAPY IN CHRONICALLY ANTICOAGULATED PATIENTS. HAEMATOLOGICA, 97(suppl. 2), 588-588.
CANCER AS A PREDICTOR FOR INCREASED PERIPROCEDURAL BLEEDING DURING SURGERY OR PLATELET-INDUCED CHEMOTHERAPY IN CHRONICALLY ANTICOAGULATED PATIENTS
SACCULLO, Giorgia;MANCUSO, Salvatrice;ABBADESSA, Vincenzo;SIRAGUSA, Sergio
2012-01-01
Abstract
Background. Patients with active cancer are often on chronic anticoagu lation and frequently require interruption of this treatment for invasive procedures and/or chemotherapy. Few data are available on the impact of cancer on periprocedural thromboembolism (TE) and major bleeding.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
PO-072.pdf
Solo gestori archvio
Descrizione: Abstract SIES 2012 PO_072
Dimensione
53.35 kB
Formato
Adobe PDF
|
53.35 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
